AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (5.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese

DEHP induces ferroptosis in testicular interstitial cells by inhibiting Fto expression

Fengqiong SUN1,2, Guowei ZHANG2, Lingqiao WANG2, Guiyong XU1, Chengwei GUO2, Yan SUN1, Rui YANG1, Lu ZHANG1, Guanghong YANG1, Ziyuan ZHOU2( ), Mingdan YOU1( )
School of Public Health, Key Laboratory of Environmental Pollution Monitoring and Disease Control of Ministry of Education, Guizhou Medical University, Guiyang, Guizhou Province, 561113
Department of Environmental Health, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038, China
Show Author Information

Abstract

Objective

To explore the role and mechanism of RNA demethylase fat mass and obesity-associated protein (FTO) in the ferroptosis in testicular interstitial cells induced by di (2-ethylhexyl) phthalate (DEHP).

Methods

Forty 3-week-old C57BL/6 male mice were randomly divided into a control group (corn oil) and 3 dosed DEHP treatment groups (5, 250 and 500 mg/kg), and received an intragastric infusion of corresponding agents for 35 d, respectively. After mouse testicular interstitial TM3 cells was treated with 0, 100, 200 and 400 μmol/L mono-2-ethylhexyl phthalate (MEHP) for 24 h, corresponding plasmids were transfected to construct Fto overexpressing TM3 cells. Serum testosterone level was detected by ELISA, expression of testicular proteins was detected with immunohistochemical assay, and contents of Fe2+, malondialdehyde (MDA) and lipid peroxides in the testicle were detected by colorimetry. Methylated RNA immunoprecipitation, RT-PCR, and Western blotting were used to detect the level of N6-methyladenosine (m6A) modification.

Results

In the mice exposed to 250 and 500 mg/kg DEHP, the serum testosterone level was significantly reduced (P<0.01), contents of Fe2+, MAD and lipid peroxides in testicular tissue were obviously increased (P<0.01), and protein levels of RNA demethylase FTO, and ferroptosis related molecules ferritin heavy chain 1 (FTH1) and glutathione peroxidase 4 (GPX4) were significantly down-regulated (P<0.05), while those of transferrin receptor (TFRC), ferroportin (FPN), cyclooxygenase-2 (COX-2), and acyl-CoA synthetase long-chain family member 4 (ACSL4) were notably up-regulated (P<0.05). MEHP treatment for 24 h resulted in remarkably decreased cell viability in the TM3 cells, increased production of intracellular reactive oxygen species (ROS), reduced mitochondrial membrane potential (MMP) (P<0.01), down-regulated mRNA and protein levels of Fto (P<0.01), and the changes in other ferroptosis related proteins were consistent with the trend in testicular tissue, indicating ferroptosis in testicular interstitial cells. Intervention with ferroptosis inhibitor Fer-1 or overexpression of Fto significantly inhibited MEHP-induced toxicity and ferroptosis in TM3 cells (P<0.05), and overexpression of Fto reduced the m6A modification of Gpx4 and Fth1 mRNA (P<0.05).

Conclusion

Abnormal m6A modification of Gpx4 and Fth1 caused by inhibiting FTO expression may be the mechanism of ferroptosis in testicular interstitial cells induced by DEHP.

CLC number: R322.64;R992;R994.6 Document code: A

References

【1】
【1】
 
 
Journal of Army Medical University
Pages 2369-2382

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
SUN F, ZHANG G, WANG L, et al. DEHP induces ferroptosis in testicular interstitial cells by inhibiting Fto expression. Journal of Army Medical University, 2024, 46(21): 2369-2382. https://doi.org/10.16016/j.2097-0927.202404119

1055

Views

36

Downloads

0

Crossref

2

Scopus

2

CSCD

Received: 25 April 2024
Revised: 19 May 2024
Published: 15 November 2024
© 2024 Journal of Army Medical University